[Translated article] Safe administration of noradrenaline by the peripheral route: A systematic review

Abstract

PurposeTo review and analyse the available literature on peripheral administration of noradrenaline (NA) with the aim of providing recommendations to ensure correct use and patient safety. MethodsSystematic review on the databases PubMed, ISI Web of Science, SCOPUS, and Science Direct, using the following search terms: (“Noradrenaline” [Mesh]) AND (“Norepinephrine” [Mesh]) AND (“Vasopressors” [Mesh]) AND (“Peripheral infusions” [Mesh]) OR (“Extravasations” [Mesh]). A total of 1040 articles were identified. Animal studies and studies written in languages other than English were excluded. Finally, 83 articles were included. ResultsNA can be administered peripherally. The risk of extravasation should be taken into account, with phentolamine being the first pharmacological line of treatment. It has also been related to the appearance of thrombophlebitis, cellulitis, tissue necrosis, limb ischaemia, and gangrene, although its incidence seems to be low. The use of peripheral NA in children seems to be carried out without obvious complications. The use of standard concentrations is suggested to reduce the risk of errors. It is recommended to use 0.9% saline as the default diluent for peripheral NA. ConclusionsPeripheral infusions of NA could be a safe and beneficial option in early resuscitation provided that a number of guidelines are followed that reduce the likelihood of complications associated with this route.